Sacubitril/Valsartan and Heart Failure, Prior SARS-CoV-2 Infection and Breakthrough Infection Following mRNA Vaccination, COVID-19 and In-Hospital Mortality With Myocardial Infarction, and more episode artwork

EPISODE · Nov 16, 2021 · 16 MIN

Sacubitril/Valsartan and Heart Failure, Prior SARS-CoV-2 Infection and Breakthrough Infection Following mRNA Vaccination, COVID-19 and In-Hospital Mortality With Myocardial Infarction, and more

from JAMA Editors' Summary

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the November 16, 2021 issue.

Episode metadata supplied by the publisher feed · Published Nov 16, 2021

Embed this episode

Ready to play

Sacubitril/Valsartan and Heart Failure, Prior SARS-CoV-2 Infection and Breakthrough Infection Following mRNA Vaccination, COVID-19 and In-Hospital Mortality With Myocardial Infarction, and more

0:00 16:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 16 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on November 16, 2021.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!